{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:00:47Z","timestamp":1787205647808,"version":"build-2736575974"},"reference-count":11,"publisher":"Walter de Gruyter GmbH","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,27]]},"DOI":"10.1515\/cclm-2023-0443","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T14:50:26Z","timestamp":1686840626000},"page":"e248-e250","source":"Crossref","is-referenced-by-count":2,"title":["Laboratory response to paradigm change in hemophilia treatment"],"prefix":"10.1515","volume":"61","author":[{"given":"Marjan","family":"Shafaati Lambert","sequence":"first","affiliation":[{"name":"Coagulation & Clinical Chemistry, Department of Molecular Medicine and Surgery , Karolinska Institutet , Stockholm , Sweden"},{"name":"Coagulation, Clinical Chemistry, Karolinska University Laboratory, Medical Diagnostics Karolinska , Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bruzelius","sequence":"additional","affiliation":[{"name":"Department of Medicine , Karolinska Institutet , Stockholm , Sweden"},{"name":"Department of Hematology , Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Mahmoud Hourani Soutari","sequence":"additional","affiliation":[{"name":"Coagulation & Clinical Chemistry, Department of Molecular Medicine and Surgery , Karolinska Institutet , Stockholm , Sweden"},{"name":"Coagulation, Clinical Chemistry, Karolinska University Laboratory, Medical Diagnostics Karolinska , Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Ranta","sequence":"additional","affiliation":[{"name":"Astrid Lindgren's Children's Hospital , Karolinska Univeristy Hospital , Stockholm , Sweden"},{"name":"Department of Women's and Children's Health , Karolinska Institutet , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan P.","family":"Antovic","sequence":"additional","affiliation":[{"name":"Coagulation & Clinical Chemistry, Department of Molecular Medicine and Surgery , Karolinska Institutet , Stockholm , Sweden"},{"name":"Coagulation, Clinical Chemistry, Karolinska University Laboratory, Medical Diagnostics Karolinska , Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"2026041716362934283_j_cclm-2023-0443_ref_001","doi-asserted-by":"crossref","unstructured":"Franchini, M, Mannucci, PM. The more recent history of hemophilia treatment. Semin Thromb Hemost 2022;48:904\u201310. https:\/\/doi.org\/10.1055\/s-0042-1756188.","DOI":"10.1055\/s-0042-1756188"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_002","doi-asserted-by":"crossref","unstructured":"Mahlangu, JN. Bispecific antibody emicizumab for haemophilia A: a breakthrough for patients with inhibitors. BioDrugs 2018;32:561\u201370. https:\/\/doi.org\/10.1007\/s40259-018-0315-0.","DOI":"10.1007\/s40259-018-0315-0"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_003","doi-asserted-by":"crossref","unstructured":"Oldenburg, J, Mahlangu, JN, Kim, B, Schmitt, C, Callaghan, MU, Young, G, et al.. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med 2017;377:809\u201318. https:\/\/doi.org\/10.1056\/nejmoa1703068.","DOI":"10.1056\/NEJMoa1703068"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_004","doi-asserted-by":"crossref","unstructured":"Pipe, SW, Shima, M, Lehle, M, Shapiro, A, Chebon, S, Fukutake, K, et al.. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4\u00a0weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study. Lancet Haematol 2019;6:e295\u2013305. https:\/\/doi.org\/10.1016\/s2352-3026(19)30054-7.","DOI":"10.1016\/S2352-3026(19)30054-7"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_005","doi-asserted-by":"crossref","unstructured":"Schmitt, C, Adamkewicz, JI, Xu, J, Petry, C, Catalani, O, Young, G, et al.. Pharmacokinetics and pharmacodynamics of emicizumab in persons with hemophilia A with factor VIII inhibitors: HAVEN 1 study. Thromb Haemostasis 2021;121:351\u201360. https:\/\/doi.org\/10.1055\/s-0040-1717114.","DOI":"10.1055\/s-0040-1717114"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_006","doi-asserted-by":"crossref","unstructured":"Peyvandi, F, Kenet, G, Pekrul, I, Pruthi, RK, Ramge, P, Spannagl, M. Laboratory testing in hemophilia: impact of factor and non-factor replacement therapy on coagulation assays. J Thromb Haemostasis 2020;18:1242\u201355. https:\/\/doi.org\/10.1111\/jth.14784.","DOI":"10.1111\/jth.14784"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_007","unstructured":"Sj\u00f6str\u00f6m, A, L\u00e5ngstr\u00f6m, S, Ranta, S, Magnusson, M, Soutari, N, Entrei, J, et al.. Laboratory measurement of emicizumab. First \u201creal-life\u201d experience from Karolinska University Laboratory. Abstract P003. Haemophilia 2020;26 S2:29."},{"key":"2026041716362934283_j_cclm-2023-0443_ref_008","doi-asserted-by":"crossref","unstructured":"Bowyer, AE, Maclean, RM, Kitchen, S. The combination of emicizumab and recombinant factor VIII in plasma: which assays can we use for accurate measurement? Int J Lab Hematol 2023;45:368\u201376. https:\/\/doi.org\/10.1111\/ijlh.14021.","DOI":"10.1111\/ijlh.14021"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_009","doi-asserted-by":"crossref","unstructured":"Bravo, MI, Ravent\u00f3s, A, P\u00e9rez, A, Costa, M, Willis, T. Non-additive effect on thrombin generation when a plasma-derived factor VIII\/von Willebrand factor (FVIII\/VWF) is combined with emicizumab in\u00a0vitro. J Thromb Haemostasis 2020;18:1934\u20139. https:\/\/doi.org\/10.1111\/jth.14887.","DOI":"10.1111\/jth.14887"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_010","doi-asserted-by":"crossref","unstructured":"Yamaguchi, T, Shinozawa, K, Nagatoishi, S, Mitsuhashi, A, Bingo, M, Inaba, H, et al.. In vitro validation of chromogenic substrate assay for evaluation of surrogate FVIII-activity of emicizumab. Thromb Res 2023;222:131\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2023.01.007.","DOI":"10.1016\/j.thromres.2023.01.007"},{"key":"2026041716362934283_j_cclm-2023-0443_ref_011","doi-asserted-by":"crossref","unstructured":"M\u00fcller, J, Pekrul, I, P\u00f6tzsch, B, Berning, B, Oldenburg, J, Spannagl, M. Laboratory monitoring in emicizumab-treated persons with hemophilia A. Thromb Haemostasis 2019;119:1384\u201393. https:\/\/doi.org\/10.1055\/s-0039-1692427.","DOI":"10.1055\/s-0039-1692427"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2023-0443\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2023-0443\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:36:40Z","timestamp":1776443800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2023-0443\/html"}},"subtitle":["How to monitor patients simultaneously treated with emicizumab and Factor VIII concentrate?"],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":11,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,15]]},"published-print":{"date-parts":[[2023,11,27]]}},"alternative-id":["10.1515\/cclm-2023-0443"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2023-0443","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}